Sign in to view content

Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Should Baseline Characteristics Affect Choice of Treatment?

Susan B. Bressler, MD, FASRS

Video
Published 2018

Related

Preoperative Intravitreal Bevacizumab for TRD Secondary to PDR: A Prospective Randomized Clinical Trial of the PACORES Group
J. Fernando Arevalo, MD, PhD, FACS, FASRS
Annual Meeting Talks
2018
SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6
Michael S. Ip, MD
Annual Meeting Talks
2018
OCT Angiography (OCTA) Monitors The Influence of Different VEGF-I Drugs on a Specific CNVM
Anne M. Hanneken, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more